CVR 37281603Private limited company (ApS)Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721900)København KFounded 3 Dec 2015
CVR holds no employment figures for this company.
Dandex has recorded no changes to this company since it began following the register.
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about Forward Pharma FA ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexResult
-35.8K
DKK, annual report 2022
Equity
39.3K
DKK, annual report 2022
Forward Pharma Operations ApSCVR 38757504, 100% of capital and votes, until 27 Oct 2023
Claus Bo Søndergaard Svendsenuntil 9 Mar 2023
No current owner is registered.
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR 28865880100% of capital and votesnotified 30 Jun 20173 Dec 2015 to 30 Jun 2017
CVR 38757504100% of capital and votes30 Jun 2017 to 27 Oct 2023
CVR lists no current officers for this company.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
3 Dec 2015 to 4 Nov 2026.
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Result for the year | -28 | -34 | -23 | -11 | -36 |
| Equity | -56 | 10 | 87 | 75 | 39 |
| Total assets | 739 | 715 | 697 | 683 | 666 |
| Credit metrics (Dandex calculations) | |||||
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | -130note 1 | -106note 1 | -88note 1 | -74note 1 | -57note 1 |
| NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender) | 56note 1 | -20note 1 | -102note 1 | -88note 1 | -71note 1 |
DKK thousands. Annual reports via XBRL.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. No cash flow statement filed (class A and B are exempt).
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 13 Jun 2023
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 1 Jun 2022
Annual report 2020
1 Jan 2020 to 31 Dec 2020, published 2 Jun 2021
Annual report 2019
1 Jan 2019 to 31 Dec 2019, published 16 Jun 2020
Annual report 2018
1 Jan 2018 to 31 Dec 2018, published 14 May 2019
Each registered value from the day it took effect, newest first.
From CVR, read 4 Nov 2026. Text such as the signing rule and purpose is shown as registered.
6 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Likvidation sluttet, og virksomheden opløst
Likvidatorer:
Fratrådte:
Thomas Hagen Weisbjerg, den 27.10.2023.
Revision:
Fratrådte:
PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB, den 27.10.2023.
Ny adresse: c/o Mazanti-Andersen, Amaliegade 10, 1256 København K
Revision:
Fratrådte:
EY Godkendt Revisionspartnerselskab, den 08.06.2023.
Tiltrådte:
CVR-NR. 33771231 PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB, Strandvejen 44, 2900 Hellerup, den 08.06.2023.
Likvidation vedtaget 09.03.2023
Likvidatorer:
Tiltrådte:
Thomas Hagen Weisbjerg, 1256 København K, den 09.03.2023.
Bestyrelse:
Fratrådte:
Jakob Mosegaard Larsen, den 09.03.2023, Florian Schønharting, (formand), den 09.03.2023, Claus Bo Søndergaard Svendsen, den 09.03.2023.
Direktion:
Fratrådte:
Claus Bo Søndergaard Svendsen, den 09.03.2023.
Virksomheden tegnes af en likvidator
Virksomhedens kreditorer opfordres til at anmelde deres krav til likvidator. Krav skal anmeldes senest tre måneder fra dags dato.
Bestyrelse:
Tiltrådte:
Claus Bo Søndergaard Svendsen, den 31.05.2017.
Direktion:
Fratrådte:
Peder Møller Andersen (adm. dir), den 31.05.2017.
Tiltrådte:
Claus Bo Søndergaard Svendsen, den 31.05.2017.
Stiftelsesdato: 03.12.2015.
Virkningsdato: 03.12.2015.
Seneste vedtægtsdato: 03.12.2015.
Kapital:
kr. 50.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 50.000,00 til kurs 1.000,00, fuldt indbetalt.
Stifter:
CVR-NR. 28865880 FORWARD PHARMA A/S, Østergade 24A, 1., 1100 København K, den 03.12.2015.
Bestyrelse:
Florian Schønharting (formand), den 03.12.2015, Jakob Mosegaard Larsen, den 03.12.2015.
Direktion:
Peder Møller Andersen (adm. dir), den 03.12.2015.
Selskabet tegnes af den samlede bestyrelse, to bestyrelsesmedlemmer eller et bestyrelsesmedlem sammen med en direktør..
Revision:
CVR-NR. 30700228 ERNST & YOUNG Godkendt Revisionspartnerselskab, Osvald Helmuths Vej 4, 2000 Frederiksberg, den 03.12.2015.
Første regnskabsår:
03.12.2015 - 31.12.2016.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er direkte eller indirekte via datterselskaber at drive aktiviteter med udvikling, fremstilling, distribution og salg af lægemidler, og enhver anden relateret virksomhed efter bestyrelsens skøn. Herudover kan selskabet deltage i samarbejder eller indgå i partnerskaber med andre virksomheder inden for sit forretningsområde, herunder udlicensiere rettigheder inden for sit forretningsområde.
1 registered in CVR.
P-number 1020955747Amaliegade 10, 1256 København K
